US move to expand supply of monkeypox vaccine
Bavarian Nordic A/S, the only manufacturer of a monkeypox vaccine approved by the Danish biotechnology FDA, said it was struggling to meet demand for the vaccine amid rising cases of the disease.
Increased demand may force the company to expand its limited manufacturing capacity by outsourcing some of its production, including at its facilities in the United States. I have. Currently, the vaccine is manufactured exclusively at Bavarian Nordic's Danish facility.
"It's a very dynamic market situation," Vice President Rolf Sass Sorensen told Bloomberg. “Demand continues to grow, and it is no longer certain that upgrading our existing manufacturing base in Denmark will continue to meet the demand we are facing.”
Bavarian Nordic did not immediately respond to CBS MoneyWatch's request for comment.
The Danish company has previously said it will produce all of its vaccines at local facilities, making it cumbersome and inefficient to transfer some of its technology to third-party producers.
However,monkeypox cases are surging around the world, and vaccines and Demand for treatment is soaring.
On August 4, the Biden administration declared monkeypox a public health emergency. Several cities and states, including New York, Illinois and California, have also declared states of emergency to combat the virus outbreak.
To date, nearly 12,700 monkeypox cases have been identified,according to the US Centers for Disease Control and Prevention.109}.California, Florida, Georgia, Illinois, New York and Texas are among the US states with the highest number of cases.
The virus is usually spread through close skin-to-skin contact or through contact with contaminated sheets or towels. The "majority" of cases in the current outbreak are among men who have sex with men, officials said.
Symptoms include painful lesions, fever, and swollen lymph nodes. This virus can also be detected using CDC lab tests.
Her Jynneos vaccine from Bavarian Nordic, approved in 2019, fights monkeypox using a modified version of the virus that prevents the virus from replicating.
Federal officials have acknowledged that the supply of Gynneos is limited and currently known close contacts of people infected with the virus We are distributing doses that can only be used by persons . Most likely infected with a virus.
— with a report from Alex Tin of CBS News.
Thank you for reading CBS NEWS.
Create a free account or log in to
for more features.